
Third time not so lucky in J&J's bid to end talc liability
Johnson & Johnson's third attempt to use bankruptcy proceedings to settle lawsuits claiming its talc-based products harmed consumers has failed.
Newsletters and Deep Dive digital magazine
Johnson & Johnson's third attempt to use bankruptcy proceedings to settle lawsuits claiming its talc-based products harmed consumers has failed.
If pharmaceuticals are included in President Trump's 'Liberation Day' tariffs, it is US consumers who will suffer the most, says a new report.
Reduction in force (RIF) job losses have started in earnest at US federal agencies, including the FDA and CDC, according to media reports.
The UK has given a world-first approval to Rotop's RoTecPSMA, a new imaging agent for detecting lesions in men with prostate cancer.
EVERSANA has joined the growing roster of companies partnering with Veeva on the development of GenAI applications for the life sciences industry.
Editor's Picks
Newsletters and Deep Dive
digital magazine